Stanford University


Showing 451-460 of 599 Results

  • David G. Mohler, MD

    David G. Mohler, MD

    Clinical Professor, Orthopaedic Surgery

    Current Research and Scholarly InterestsDr. Mohler is involved in gene expression in sarcomas, and innovative anatomy-preserving surgical management of low grade chondrosarcomas.

  • Parviz Moin

    Parviz Moin

    Franklin P. and Caroline M. Johnson Professor in the School of Engineering

    BioMoin is the founding director of the Center for Turbulence Research. Established in 1987 as a research consortium between NASA and Stanford, Center for Turbulence Research is devoted to fundamental studies of turbulent flows. Center of Turbulence Research is widely recognized as the international focal point for turbulence research, attracting diverse groups of researchers from engineering, mathematics and physics. He was the founding director of the Institute for Computational and Mathematical Engineering at Stanford.

    Professor Moin pioneered the use of direct and Large Eddy Simulation techniques for the study of turbulence physics, control and modelling concepts and has written widely on the structure of turbulent shear flows. His current interests include: Computational physics, Physics and control of turbulent boundary layers, hypersonic flows, propulsion, flow control, large eddy simulation for aerospace applications and aircraft icing.

  • James M. Mok, MD

    James M. Mok, MD

    Clinical Associate Professor, Orthopaedic Surgery

    BioDr. Mok is a board-certified, fellowship-trained spine surgeon with the Stanford Medicine Spine Center in Redwood City. He is also a clinical associate professor of medicine in the Department of Orthopaedic Surgery.

    Dr. Mok diagnoses and treats a wide range of degenerative spine conditions, including disc herniations, spinal stenosis, myelopathy, and spondylolisthesis, as well as patients who have had previous spine surgery. He specializes in minimally invasive surgical techniques and strives to perform the least invasive procedures with the highest chances of success. His surgical specialties include minimally invasive microdiscectomy and laminectomy, minimally invasive spinal fusion, and artificial disc replacement.

    Prior to Stanford, Dr. Mok worked as an orthopaedic spine surgeon with the NorthShore Orthopaedic and Spine Institute, the only dedicated orthopedic specialty hospital in the Chicago region. He was previously Associate Professor of Orthopaedic Surgery and Rehabilitation Medicine at the University of Chicago.

    Dr. Mok served on active duty in the United States Army Medical Corps with the rank of Major. His military experience included deployment to the Iraq theater as an orthopaedic surgeon and spine surgery consultant.

    Dr. Mok has published work in many leading journals in his field, including The Spine Journal, Spine, and Journal of Bone and Joint Surgery. He has presented to his peers at international, national, and regional meetings, including annual meetings of the North American Spine Society, the Society for Minimally Invasive Spine Surgery, and the American Association of Orthopaedic Surgeons.

    Dr. Mok is a member of the American Academy of Orthopaedic Surgeons, the American Orthopaedic Association, the North American Spine Society, the Scoliosis Research Society, and the Society for Minimally Invasive Spine Surgery.

  • Pedram Mokrian

    Pedram Mokrian

    Lecturer
    Instructor, Stanford Center for Professional Development

    BioPedram Mokrian is Adjunct Professor at Stanford University and a lecturer at the Haas School of business at UC Berkeley where he teaches and advises entrepreneurs and global 1000 companies alike on entrepreneurship, business model disruption, and technology innovation strategy. He was previously a Principal at Mayfield, one of Silicon Valley’s most storied venture capital firms, where he was part of the investment team with over $3.5B assets under management. Mokrian is a founding Partner of the Ratio Academy, New Line Ventures. He also serves as a mentor or advisor to a number of start-ups, innovation incubators, including Global Innovation Catalyst, the Texas Medical Center Innovation Center, Innovation Labs, MISO, and Moog, and serves on the advisory board of Phillips66.

  • J. Moldowan

    J. Moldowan

    Professor (Research) of Geological and Environmental Sciences, Emeritus

    Current Research and Scholarly InterestsOrganic geochemistry; study of molecular fossils (biomarkers) and their use in petroleum system analysis, reservoir characterization, environmental monitoring, molecular paleontology, global change, petroleum biodegradation in reservoir. Studies of thermal cracking of petroleum by deep burial or catalytic alteration in deep source rocks and reservoirs by using diamondoids. Applications to unconventional petroleun exploration and development.

  • Matteo Amitaba Mole'

    Matteo Amitaba Mole'

    Assistant Professor of Obstetrics and Gynecology (Reproductive & Stem Cell Biology)

    Current Research and Scholarly InterestsThe research focus of our laboratory is centered on investigating the complex process of human embryo implantation. Due to the limited availability of suitable model systems and inability to directly observe this process in vivo, this has been traditionally referred to as the enigmatic stage of human embryonic development.

    The successful implantation of an embryo is crucial for the establishment of a healthy pregnancy. During the transition between the first and second week of gestation, the human embryo must securely implant into the maternal uterus, initiating development of the placenta to receive necessary nutrients and oxygen for its growth until birth.

    However, the process of implantation in humans is highly susceptible to failure, with a significant percentage of embryos unable to develop beyond this stage leading to early miscarriages. This clinically observed "implantation barrier" often requires patients to undergo numerous cycles of IVF treatment, with no guarantee of a successful pregnancy outcome.

    The primary objective is to increase the understanding of maternal-embryo interactions initiated at implantation, with the goal of developing clinical interventions to address the high incidence of implantation failures underlying pre-clinical miscarriages.